NLM Digital Collections

Search

Start Over Subjects Child ✖Remove constraint Subjects: Child Publication Year 2019 ✖Remove constraint Publication Year: <span class="single" data-blrl-single="2019">2019</span>

12. Benefits and services

Author(s):
Raduege, Tammy, author
Publication:
[Toronto, Ontario] : Thomson Reuters, 23-December-2019
Subject(s):
Insurance Benefits -- legislation & jurisprudence
Medicaid -- economics
Medicaid -- legislation & jurisprudence
Budgets
Child
Child Health Services -- legislation & jurisprudence
Community Health Services -- legislation & jurisprudence
Dental Health Services -- legislation & jurisprudence
Home Care Services -- legislation & jurisprudence
Insurance, Pharmaceutical Services -- legislation & jurisprudence
Long-Term Care -- legislation & jurisprudence
Mental Health Services -- legislation & jurisprudence
Oral Health -- legislation & jurisprudence
Reproductive Health Services -- legislation & jurisprudence
State Government
Transportation of Patients -- legislation & jurisprudence
Humans
United States
United States.

13. Pediatric HIV infection: drug product development for treatment

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, March 2019
Subject(s):
Drug Development -- standards
HIV Infections -- drug therapy
Pediatrics
Adolescent
Anti-Retroviral Agents -- therapeutic use
Child
Clinical Trials as Topic
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

14. Human immunodeficiency virus-1 infection: developing systemic drug products for pre-exposure prophylaxis

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, March 2019
Subject(s):
Drug Development
HIV Infections -- prevention & control
Pre-Exposure Prophylaxis
Adolescent
Child
Clinical Trials as Topic
HIV Infections -- drug therapy
HIV-1
Infant
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

15. Pediatric information incorporated into human prescription drug and biological product labeling

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, March 2019
Subject(s):
Drug Labeling -- standards
Pediatrics
Product Labeling -- standards
Adolescent
Biological Products
Child
Child, Preschool
Infant
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

17. Drugs for treatment of partial onset seizures: full extrapolation of efficacy from adults to pediatric patients 2 years of age and older

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, September 2019
Subject(s):
Anticonvulsants -- therapeutic use
Clinical Trials as Topic
Drug Development -- standards
Seizures -- drug therapy
Adolescent
Anticonvulsants -- pharmacology
Child
Child, Preschool
Safety
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

18. Compliance policy for limited modifications to certain marketed tobacco products

Publication:
Silver Spring, MD : Center for Tobacco Products, November 2019
Subject(s):
Electronic Nicotine Delivery Systems -- standards
Nicotine -- adverse effects
Tobacco Products -- adverse effects
Child
Consumer Product Safety
Equipment Failure
Product Packaging
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

20. Many Medicaid-enrolled children who were treated for ADHD did not receive recommended followup care

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, August 2019
Subject(s):
Aftercare
Attention Deficit Disorder with Hyperactivity -- drug therapy
Attention Deficit Disorder with Hyperactivity -- therapy
Follow-Up Studies
Medicaid
Behavior Therapy
Child
Medication Therapy Management
Quality Indicators, Health Care
Humans
United States